MedTrace Logo

Effects of N-acetyl Cystein (NAC) Supplementation in G6PD Deficient Individuals After Acute Exercise

NCT02937376 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2022-01-05

No results posted yet for this study

Summary

The purpose of this study is to investigate the effects of N-acetyl Cystein (NAC) supplementation on redox status, physiological and biochemical parameters in G6PD deficient individuals after acute exercise.

Conditions

  • G6PD Deficiency

Interventions

DRUG

N-acetyl cystein

A trial of exercise before and after 4 weeks of N-acetyl cystein (NAC) supplementation.

OTHER

Placebo

A trial of exercise before and after 4 weeks of placebo administration.

Sponsors & Collaborators

  • University of Thessaly

    lead OTHER

Principal Investigators

  • Athanasios Z Jamurtas, PhD · University of Thessaly

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2023-06-01
Completion
2023-11-01

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02937376 on ClinicalTrials.gov